Alberto Russu

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study

Maarten Timmers, Johannes Streffer, Alberto Russu et al. · Alzheimer s Research & Therapy · 2018 · 106 citations · Full text

Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study

Gerald Novak, Johannes Streffer, Maarten Timmers et al. · Alzheimer s Research & Therapy · 2020 · 98 citations · Full text

Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ‐54861911, a potent oral BACE inhibitor

Maarten Timmers, Bianca Van Broeck, Steven Ramael et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2016 · 59 citations · Full text

Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia

Mats O. Magnusson, Mahesh N. Samtani, Elodie L. Plan et al. · Clinical Pharmacokinetics · 2016 · 32 citations

Paliperidone Palmitate, Psychiatry, Months Intramuscular Formulation +8

Alzheimer's disease assessment scale‐cognitive 11‐item progression model in mild‐to‐moderate Alzheimer's disease trials of bapineuzumab

Mahesh N. Samtani, Steven Xu, Alberto Russu et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2015 · 21 citations · Full text